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Abstract 
Review on PDSS2, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: C6orf210, COQ10D3, DLP1, 
bA59I9.3, hDLP1 
HGNC (Hugo): PDSS2 
Location: 6q21 
Local order 
According to NCBI Map Viewer, several genes 
flank PDSS2 in the order from centromere to 
telomere direction on chromosome: 6; 
NC_000006.11:  
- C6orf203, chromosome 6 open reading frame 203, 
location: 6q21;  
- BEND3, BEN domain containing 3, location: 
6q21;  
- RPS24P12, ribosomal protein S24 pseudogene 12, 
location: 6q21;  
- PDSS2, 6q21;  
- SOBP, sineoculis binding protein homolog 
(Drosophila), location: 6q21. 
 
 
DNA/RNA 
Description 
PDSS2 gene has 307.02 kb of genomic DNA on the 
reverse strand, containing 8 exons. 
Transcription 
The full transcript is a 3568 bp mRNA with 1200 
bp open reading frame. This gene has 4 transcripts 
(splice variants, PDSS2-001 to 004). All transcripts 
are protein coding. The length of the 4 splice 
variants are 3540 bp (399 aa), 1338 bp (297 aa), 
1236 bp (240 aa) and 241 bp (80 aa) respectively. 
Protein 
Human decaprenyl diphosphate synthase is a 
hetero-tetramer composed of DPS1 (PDSS1; 
NM_014317) and DLP1 (PDSS2) subunits that 
produces the ubiquinone coenzyme Q10. 
The isoprenoid chain of ubiquinone (coenzyme Q) 
varies in length between species and is determined 
by trans-polyprenyl diphosphate synthase. 
Other names: decaprenyl pyrophosphate synthetase 
subunit 2; prenyl diphosphate synthase, subunit 2; 
subunit 2 of decaprenyl diphosphate synthase. 
 
 
Diagram of the PDSS2 gene (isoform1/Dlp1). Exons are represented by open boxes (in yellow). Exons 1 to 8 are from the 5' to 
3' direction. 
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Diagram of 2 isoforms of PDSS2 protein (DLP1and DLP2). 
 
 
Description 
The complete translation product is a 44 kDa 
protein containing 399 amino acids. It is the non-
catalyzing subunit of prenyl diphosphate synthase, 
the first enzyme in CoQ10 biosynthesis. However it 
is essential for the activity of the enzyme. Its 
mutations could cause CoQ10 deficiency and 
contributes to nephritic and metabolic diseases and 
neuromuscular defects. 
It is also a candidate tumor suppressor protein, and 
was found down-regulated in melanoma, gastric 
cancer and non-small-cell lung cancers. 
A mutated protein was identified by Saiki et al. 
(2005) that contains the 7 conserved domains 
typically found in all trans-prenyl diphosphate 
synthases, but it lacks DDxxD motifs which could 
be involved in the catalytic mechanism and/or the 
binding of the substrates. 
Expression 
According to AceView, this gene is expressed at 
high level, 2.1 times the average genes, observed 
from 226 cDNA clones. 
Northern blot analysis shows PDSS2 expresses two 
transcripts: 3.5 and 1.2 kb. The 3.5-kb transcript 
was expressed strongly in heart, prostate, and testis; 
moderately in brain, kidney, liver, lung, spleen, 
duodenum, esophagus, pancreas, thymus, and 
thyroid; and weakly in colon, muscle, small 
intestine, salivary gland, and uterus, and was absent 
in stomach, peripheral blood lymphocyte, and 
urinary bladder. Expression of the 1.2-kb transcript 
was detected in heart, kidney, liver, pancreas, 
prostate, testis, thymus, and thyroid. 
Localisation 
Cytoplasm, organelle, mitochondria. 
Function 
It is the 2nd subunit of decaprenyl diphosphate 
synthase, which catalyzes the first and critical step 
in coenzyme Q biosynthesis: the formation of all 
trans-polyprenyl pyrophosphates from isopentyl 
diphosphate in the assembly of polyisoprenoid side 
chains. The step is critical in coenzyme Q 
biosynthesis. It is not the catalytic subunit but is 
essential for the catalytic activity. 
Related super-pathways: Metabolic pathways, 
apoptosis, geranyldiphosphate biosynthesis, trans-
octaprenyl transferase activity and protein 
heterodimerization activity. 
Protein interaction: PDSS2 protein can interact 
with apoptotic protease-activating factor 1 (APAF1, 
DIP27624N), which mediates the cytochrome c-
dependent autocatalytic activation of pro-caspase-9 
(Apaf-3), leading to the ATP required activation of 
caspase-3 and apoptosis. Result from in silicon 
pathway analysis showed that PDSS2 protein could 
interact with hepatocyte nuclear factor 4 alpha 
(HNF4a), a nuclear transcription factor which 
regulates the expression of many genes involved in 
cell growth and proliferation. 
Homology 
PDSS2 gene is conserved in human, Rhesus 
monkey, dog, cow, mouse, rat, chicken, zebrafish, 
fruit fly, and mosquito. 
Mutations 
Note 
PDSS2, GLN322TER [dbSNP:rs118203955]  
PDSS2, SER382LEU [dbSNP:rs118203956]  
Disease: Primary coenzyme Q10 deficiency-3 
(COQ10D3; OMIM614652). 
Two compound heterozygous mutations in the 
PDSS2 gene were identified by López et al. (2006) 
in an infant with fatal encephalomyopathy and 
nephrotic syndrome due to coenzyme Q10 
deficiency-3 (COQ10D3; 614652): 2 mutations in 
the PDSS2 gene: a 964C-T transition resulting in a 
gln322-to-ter (Q322X,610564.0001) substitution 
inherited from the unaffected father; and a 1145C-T 
transition resulting in a ser382-to-leu (S382L; 
610564.0002) substitution in the seventh conserved 
domain inherited from the unaffected mother 
(López et al., 2006).  
In fibroblasts derived from the patient reported by 
López et al. (2006). CoQ10 levels were decreased 
to 22.4% of normal, and the cells showed reduced 
ATP levels (50% of controls), but no increase in 
reactive oxygen species, signs of oxidative stress, 
increased antioxidant defense markers,or oxidative 
stress-induced cell death (Quinzii et al., 2008; 
Quinzii et al., 2010). This suggested that the 
pathology caused by these PDSS2 mutations was 
related to the marked bioenergetic defect, but not to 
oxidative stress.  
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Diagram of PDSS2 possible pathway involved in produce lung cancer cells death through apoptosis. 
 
The very low mitochondrial respiratory activity 
may even confer some resistance to stress-induced 
apoptosis.  
PDSS2 polymorphisms  
Disease: Leigh syndrome with nephropathy  
A pair of proxy SNPs of PDSS2 was significantly 
associated with podocyte diseases, and patients 
homozygous for one PDSS2 haplotype had a 
strongly increased risk for podocyte disease. A 
deficiency of coenzyme Q10 is manifested in 
lymphoblastoid cell lines derived from focal 
segmental glomerulosclerosis patients (Gasser et 
al., 2013). 
Implicated in 
Gastric cancer 
Note 
PDSS2 may be a potent gastric cancer growth 
suppressor in vitro acting through apoptosis 
pathways. By transfecting PDSS2 to gastric cancer 
cell line SGC7901, Chen et al. found that 
expression of PDSS2 can induce apoptosis in 
human gastric cancer SGC7901 cells, block cell at 
G0/G1 stage, and inhibit cell proliferation.  
Expression of PDSS2 is downregulated in human 
gastric cancer (84.6%, 33/39), and the degree of 
expression degraded with the increase of malignant 
degree of tumor. In poorly differentiated gastric 
cancer, the negative or low expression of PDSS2 
was 35% (7/20) or 55% (11/20) and in moderately 
differentiated gastric cancer, it was 10.5% (2/19) or 
68.4% (13/19), respectively (Chen et al., 2009). 
Melanoma 
Note 
Down-regulation of PDSS2 was observed in 59 of 
87 (67.8%) primary melanomas, which was 
significantly higher than that in benign nevi (7 of 
66, 10.6%). An overexpression of the PDSS2 in 
UACC-903 cells could inhibit tumor cell growth, 
decrease the colony-forming ability in soft agar, 
and totally abrogate the tumorigenicity of UACC-
903 in nude mice. Fung et al. proposed that PDSS2 
is a novel tumor suppressor gene that plays an 
important role in the development of malignant 
melanoma (Fung et al., 2009).  
The sequence of PDSS2 (AF254956) was firstly 
submitted to National Cancer for Biotechnology 
Information by the authors in 2000 and was then 
named as C6orf210 by Human Genome 
Organization. Then C6orf210 was found to be 
important in determining the length of the side 
chain of ubiquinone in mammals and was named as 
PDSS2 (Saiki et al., 2005). 
Non-small cell lung cancer 
Note 
Non-small cell carcinomas (NSCLC) are divided 
into non-small cell lung cancer accounts for 
approximately 85% of all lung cancers. It is divided 
further into three main categories: adenocarcinoma, 
squamous cell carcinoma (SCC), and large cell 
carcinoma histologies. 6q16.3-21 LOH has been 
found in 78% of SCLCs. PDSS2 gene is located in 
the frequent LOH region of 6q16.3-21, implying for 
its potential role as tumor suppressor. Loss of 
PDSS2 expression is associated with non-small cell 
lung cancer. Decrease in PDSS2 expression was 
more severe in poorly and poor-to-moderately 
differentiated lung cancers, more in higher 
pathological stage and in patients with lymph node 
metastasis. The decrease in PDSS2 expression in 
tumor tissues was not related to sex or histological 
type of NSCLC, but was related to smoking history 
(Chen et al., 2013). 
The PDSS2 gene has low expression levels in 
human lung cancer cell lines. The forced PDSS2 
overexpression caused massive cell death through 
apoptotic pathways and significantly inhibited 
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colony formation in the NCI-H1299 lung cancer 
cell line. At the same time, repression of PDSS2 
expression by siRNA enhanced the growth of a 
noncancerous lung epithelial cell line MRC-5. 
There was an inverse correlation between PDSS2 
expression and gelsolin expression, which is known 
to inhibit apoptosis and enhance cell invasion and 
metastasis. The ability of PDSS2 to repress gelsolin 
might contribute to its tumor-suppressing activity. 
However, PDSS2 did not influence the sensitivity 
of the lung cancer cells to chemotherapeutic drugs. 
Taken together, PDSS2 has tumor-suppressing 
activity in human lung cancer cells by enhancing 
apoptosis and inhibiting tumorigenic capacity 
(Chen et al., 2014). 
Breakpoints 
Note 
Studies have reported the potential of the PDSS2 
gene as a tumor suppressor in gastric cancer, lung 
cancer, and melanoma. First, the PDSS2 gene is 
located in the chromosome region of 6q16.3-21, 
where frequent LOH occurs in lung cancers, 
implying the loss of PDSS2 expression and 
function in lung cancers. Second, PDSS2 protein is 
essential for the enzyme activity of prenyl 
diphosphate synthase, which is a critical enzyme in 
CoQ10 biosynthesis. Decreased PDSS2 level can 
lead to CoQ10 deficiency. CoQ10 is the 
predominant human form of endogenous 
ubiquinone, and plays a vital role in the 
mitochondrial respiratory chain as the carrier of 
electrons from complexes I and II to complex III. 
Its reduced form is one of the most potent lipophilic 
antioxidants in all cell membranes. CoQ10 also 
participates in pyrimidine nucleoside biosynthesis 
and may modulate apoptosis and the mitochondrial 
uncoupling protein.  
By depletion of CoQ10, decrease in PDSS2 may 
contribute toward the initiation and progression of 
tumor through deregulated mitochondria function 
and increased intracellular oxidative stress.  
Overexpression of PDSS2 induced apoptosis in 
cancer cells.  
The mechanism is not clear. A possible mechanism 
could be that CoQs including CoQ10 can 
selectively inhibit DNA topoisomerase II (topo-II) 
activity and eukaryotic DNA polymerase-γ, which 
is a mitochondrial DNA polymerase, and thus 
inhibit DNA synthesis and mitochondrial 
proliferation and consequently induce cancer cell 
death.  
An inverse correlation of PDSS2 expression and 
gelsolin expression was reported. Gelsolin has been 
shown to inhibit apoptosis by blocking 
mitochondrial membrane potential loss and 
cytochrome c release, thus stabilizing mitochondria. 
Repression of gelsolin by PDSS2 may counteract 
the mitochondrial stabilization, and thus induce 
apoptosis in cancer cells.  
PDSS2 does not influence the chemosensitivity of 
lung cancer cells. 
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